Please login to the form below

Not currently logged in

ABPI/ BIA relocate together

The UK's Association of the British Pharmaceutical Industry and the BioIndustry Association are to relocate to shared offices in London by the end of May

The UK's Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) are to relocate to shared offices in the Victoria region of London by the end of May.

The bodies, each representing its respective area of life sciences, will remain independent organisations, although the move will 'faciliate more effective joint working on cross-industry issues' according to a shared statement.

Announcing the move, Dr Richard Barker, director general of the ABPI, commented on increased collaborative efforts with the BIA since the establishment of the UK Office for Life Sciences in April 2009 to address key issues affecting the pharmaceutical, medical biotech and devices sectors.

He said: "Our organisations have been able to operate more strategically, and more effectively, by representing the life sciences sector with one voice, alongside the ABHI [Association of British Healthcare Industries] and BIVDA [British In Vitro Diagnostics Association]. This move strengthens a joint determination that the UK remain a great place to invest and do business in life sciences."

Nigel Gaymond, chief executive of the BIA, also championed the decision: "The UK has exceptional strengths in life sciences. Establishing a central venue where those with an interest in life sciences can access the combined expertise of the BIA and ABPI will enable us to highlight more effectively all that the UK has to offer."

16th May 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....